000013562 000__ 01480cam\a22003735i\4500
000013562 001__ 13562
000013562 003__ SzGeWIPO
000013562 005__ 20210318092604.0
000013562 008__ 041027s2002\\\\mau\\\\\r\\\\u000\0\eng\d
000013562 035__ $$a(wipo)(CD )04-0566
000013562 035__ $$a(OCoLC)1161116392
000013562 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000013562 084__ $$aG 25 HUG.N
000013562 090__ $$c14282$$d14282
000013562 1001_ $$aHughes, James W.,$$eauthor.
000013562 24511 $$a"Napsterizing" pharmaceuticals :$$baccess, innovation, and consumer welfare /$$cJames W. Hughes.
000013562 264_1 $$aCambridge, Ma :$$bNational Bureau Of Economic Research,$$c2002.
000013562 300__ $$a54 pages ;$$c[28] cm.
000013562 336__ $$atext$$btxt$$2rdacontent
000013562 337__ $$aunmediated$$bn$$2rdamedia
000013562 338__ $$avolume$$bnc$$2rdacarrier
000013562 4901_ $$aNber Working Paper Series (no. 9229)
000013562 500__ $$aThis article was downloaded and printed from the RePEc online archive. It was published in October 2002 as Working Paper 9229 in the National Bureau of Economic Research working paper series. See also www.nber.org/papers/w9229.
000013562 650_4 $$aPHARMACEUTICAL INDUSTRY
000013562 650_4 $$aDRUGS, PHARMACEUTICALS, MEDICINES
000013562 650_4 $$aACCESS TO MEDICINE
000013562 650_4 $$aPHARMACEUTICAL PATENTS
000013562 7001_ $$aMoore, Michael J.
000013562 7001_ $$aSnyder, Edward A.
000013562 830_0 $$aNber Working Paper Series (no. 9229)
000013562 903_0 $$aNBER Working Paper Series (no. 9229)$$v1
000013562 942__ $$cMON
000013562 952__ $$w2006-11-03$$p2004-0566$$r0.00$$u15186$$bMAIN$$10$$kG 25 HUG.N$$v2004-10-27$$ztagged$$71
000013562 980__ $$aBIB
000013562 999__ $$c14282$$d14282